The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
You can repeat as much as you like. Its worth what the market values it at. At the moment thats 2.6p.
What ever this company says needs a very large pinch of salt with it imo and it would seem I'm not the only one.
The proof or not as the case might be will be in the revenue down the line. What ever WSG say at the off, is being ignored.
Why is that I wonder?
Jim; These are some of the Docs posts. Apparently from Pete-
17th April - “They've not placed in 3 years and Fowler has continually said they won't and specifically they won't for this deal.”
11th April “Fowler has stated many times they will not use equity for this contract and there is no reason to doubt him now after 3 years without a placement, when that is confirmed with UKEF funding etc it is an additional green light for SP rise.”
9th April “There will be no equity raise until at least double digits and only then for a little bit of grease to make some bigger moves.
Can I also echo what fry has said. Despite our difference of opinion I honestly won't mind one bit being wrong here and you and all the genuine investors make a packet. I only lurk here because LSE won't let me see posts without an account any longer!
I'll try and stay out of things best i can lol
Out of interest, Woody, did you slice any at close to 4p to reduce your risk a little?